# A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

> **NCT03570359** · PHASE2 · COMPLETED · sponsor: **Synairgen Research Ltd.** · enrollment: 122 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Interferon Beta-1A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03570359
- **Lead sponsor:** Synairgen Research Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-29
- **Primary completion:** 2020-05-05
- **Final completion:** 2020-05-05
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2023-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570359, "A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03570359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*